CA3207834C - ANIMALS INCLUDING IL-4 AND IL-4R ALPHA HUMANIZED - Google Patents

ANIMALS INCLUDING IL-4 AND IL-4R ALPHA HUMANIZED

Info

Publication number
CA3207834C
CA3207834C CA3207834A CA3207834A CA3207834C CA 3207834 C CA3207834 C CA 3207834C CA 3207834 A CA3207834 A CA 3207834A CA 3207834 A CA3207834 A CA 3207834A CA 3207834 C CA3207834 C CA 3207834C
Authority
CA
Canada
Prior art keywords
human
gene
rodent
mouse
humanized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3207834A
Other languages
English (en)
French (fr)
Other versions
CA3207834A1 (en
Inventor
Li-Hsien Wang
Yingzi XUE
Andrew J. Murphy
Sean Stevens
Original Assignee
Regeneron Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharmaceuticals Inc filed Critical Regeneron Pharmaceuticals Inc
Priority to CA3207834A priority Critical patent/CA3207834C/en
Publication of CA3207834A1 publication Critical patent/CA3207834A1/en
Application granted granted Critical
Publication of CA3207834C publication Critical patent/CA3207834C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5406—IL-4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/20—Animal model comprising regulated expression system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/035—Animal model for multifactorial diseases
    • A01K2267/0368—Animal model for inflammation
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0393—Animal model comprising a reporter system for screening tests

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Environmental Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA3207834A 2014-05-07 2015-05-07 ANIMALS INCLUDING IL-4 AND IL-4R ALPHA HUMANIZED Active CA3207834C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA3207834A CA3207834C (en) 2014-05-07 2015-05-07 ANIMALS INCLUDING IL-4 AND IL-4R ALPHA HUMANIZED

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201461989757P 2014-05-07 2014-05-07
US61/989,757 2014-05-07
CA2947307A CA2947307C (en) 2014-05-07 2015-05-07 Humanized il-4 and il-4r .alpha. animals
CA3207834A CA3207834C (en) 2014-05-07 2015-05-07 ANIMALS INCLUDING IL-4 AND IL-4R ALPHA HUMANIZED

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA2947307A Division CA2947307C (en) 2014-05-07 2015-05-07 Humanized il-4 and il-4r .alpha. animals

Publications (2)

Publication Number Publication Date
CA3207834A1 CA3207834A1 (en) 2015-11-12
CA3207834C true CA3207834C (en) 2025-10-14

Family

ID=53284509

Family Applications (2)

Application Number Title Priority Date Filing Date
CA2947307A Active CA2947307C (en) 2014-05-07 2015-05-07 Humanized il-4 and il-4r .alpha. animals
CA3207834A Active CA3207834C (en) 2014-05-07 2015-05-07 ANIMALS INCLUDING IL-4 AND IL-4R ALPHA HUMANIZED

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CA2947307A Active CA2947307C (en) 2014-05-07 2015-05-07 Humanized il-4 and il-4r .alpha. animals

Country Status (26)

Country Link
US (7) US9565841B2 (OSRAM)
EP (3) EP3281521B1 (OSRAM)
JP (5) JP6640740B2 (OSRAM)
KR (2) KR102473565B1 (OSRAM)
CN (2) CN110269047B (OSRAM)
AU (3) AU2015255977B2 (OSRAM)
BR (1) BR112016025745A2 (OSRAM)
CA (2) CA2947307C (OSRAM)
CY (2) CY1119773T1 (OSRAM)
DK (2) DK3281521T3 (OSRAM)
ES (2) ES2887852T3 (OSRAM)
HR (2) HRP20211455T1 (OSRAM)
HU (2) HUE055860T2 (OSRAM)
IL (3) IL304841B1 (OSRAM)
LT (2) LT3027015T (OSRAM)
MX (1) MX370672B (OSRAM)
NO (1) NO2785538T3 (OSRAM)
PH (1) PH12016502058A1 (OSRAM)
PL (2) PL3281521T3 (OSRAM)
PT (2) PT3281521T (OSRAM)
RS (2) RS57073B1 (OSRAM)
RU (1) RU2703139C2 (OSRAM)
SG (2) SG11201608570YA (OSRAM)
SI (2) SI3027015T1 (OSRAM)
SM (2) SMT201800018T1 (OSRAM)
WO (1) WO2015171861A1 (OSRAM)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO2785538T3 (OSRAM) 2014-05-07 2018-08-04
CN106604635B (zh) 2014-06-19 2020-01-14 瑞泽恩制药公司 具有人源化程序性细胞死亡1基因的非人动物
KR102422356B1 (ko) * 2014-09-17 2022-07-18 오를리콘 서피스 솔루션스 아크티엔게젤샤프트, 페피콘 내마모성이 향상된 이중층 코팅 절삭 공구의 제조 방법
DK3223605T3 (da) 2014-11-24 2020-11-16 Regeneron Pharma Ikke-humane dyr, der eksprimerer humaniseret cd3-kompleks
EP3086637B1 (en) 2014-12-05 2019-01-02 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized cluster of differentiation 47 gene
MX2017007636A (es) 2014-12-09 2018-03-28 Regeneron Pharma Animales no humanos que tienen un gen del grupo de diferenciacion 274 humanizado.
AU2016358101B2 (en) 2015-11-20 2022-12-01 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized Lymphocyte-activation gene 3
KR102487839B1 (ko) 2016-02-04 2023-01-12 리제너론 파마슈티칼스 인코포레이티드 조작된 angptl8 유전자를 갖는 비인간 동물
SG10202001578RA (en) * 2016-02-29 2020-04-29 Regeneron Pharma Rodents having a humanized tmprss gene
TWI784988B (zh) * 2016-12-01 2022-12-01 美商再生元醫藥公司 治療發炎症狀的方法
MX2019012171A (es) 2017-04-13 2019-11-25 Regeneron Pharma Tratamiento e inhibicion de enfermedades pulmonares inflamatorias en pacientes que tienen alelos de riesgo en los genes que codifican la il33 e il1rl1.
CN118994394A (zh) 2017-06-12 2024-11-22 蓝鳍生物医药公司 抗-il1rap抗体和抗体药物缀合物
EP3585162B1 (en) 2017-09-29 2023-08-30 Regeneron Pharmaceuticals, Inc. Rodents comprising a humanized ttr locus and methods of use
CA3076377A1 (en) 2017-11-30 2019-06-06 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized trkb locus
CA3093850A1 (en) 2018-03-26 2019-10-03 Regeneron Pharmaceuticals, Inc. Humanized rodents for testing therapeutic agents
IL277890B2 (en) 2018-04-11 2024-03-01 Regeneron Pharma Methods for quantifying il-33
JP7048051B2 (ja) 2018-07-11 2022-04-05 正徳 染井 痒みを軽減するアトピー性皮膚炎治療剤
SMT202400300T1 (it) * 2018-07-16 2024-09-16 Regeneron Pharma Modelli di roditori della sindrome ditra e loro utilizzo
WO2020074005A1 (en) 2018-10-12 2020-04-16 Beijing Biocytogen Co., Ltd Genetically modified non-human animal with human or chimeric genes
CN111218425B (zh) * 2019-01-17 2022-02-08 百奥赛图(北京)医药科技股份有限公司 人源化转基因动物
CN117178959A (zh) 2019-04-04 2023-12-08 瑞泽恩制药公司 包括人源化凝血因子12基因座的非人动物
AU2020286382A1 (en) 2019-06-04 2021-11-04 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized TTR locus with a beta-slip mutation and methods of use
MX2021015122A (es) 2019-06-07 2022-04-06 Regeneron Pharma Animales no humanos que comprenden un locus de albumina humanizado.
CN112300265B (zh) * 2019-07-29 2022-09-27 百奥赛图(北京)医药科技股份有限公司 Il33基因人源化的非人动物的构建方法和应用
WO2021027737A1 (en) * 2019-08-09 2021-02-18 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Genetically modified non-human animal with human or chimeric il2ra
US20220378025A1 (en) * 2019-11-11 2022-12-01 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Genetically modified non-human animal with human or chimeric genes
CN114786479B (zh) * 2019-12-25 2023-12-15 江苏集萃药康生物科技股份有限公司 一种il-15人源化小鼠模型及其用途
WO2021154791A1 (en) * 2020-01-28 2021-08-05 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized pnpla3 locus and methods of use
CN111149767B (zh) * 2020-02-24 2021-07-20 中南大学湘雅二医院 一种人源化皮肤型红斑狼疮小鼠模型的构建方法和应用
CN113527485B (zh) * 2020-04-17 2024-11-15 湖南麦济生物技术股份有限公司 抗人白细胞介素-4受体α抗体及其制备方法和应用
CN111808882B (zh) * 2020-09-01 2020-12-29 北京百奥赛图基因生物技术有限公司 Il7r基因人源化改造的动物模型的构建方法及其应用
CN111793646B (zh) * 2020-09-08 2021-01-15 北京百奥赛图基因生物技术有限公司 Il1r1基因人源化改造的非人动物的构建方法及其应用
CN111926039B (zh) * 2020-09-23 2021-03-16 百奥赛图(北京)医药科技股份有限公司 Il-13基因人源化的非人动物的构建方法和应用
CA3171455A1 (en) * 2020-12-21 2022-06-30 Yajun Tang Non-human animals having a humanized tslp gene, a humanized tslp receptor gene, and/or a humanized il7ra gene
WO2022247936A1 (en) * 2021-05-28 2022-12-01 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Genetically modified non-human animal with human or chimeric cd36
WO2024067796A1 (zh) * 2022-09-28 2024-04-04 百奥赛图(北京)医药科技股份有限公司 一种il5和/或il5ra基因人源化修饰的非人动物
WO2024151707A1 (en) * 2023-01-11 2024-07-18 Regeneron Pharmaceuticals, Inc. Systems and methods for a regulatory-compliant automated assay
WO2025175099A1 (en) 2024-02-16 2025-08-21 Regeneron Pharmaceuticals, Inc. A rodent copd model

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990005183A1 (en) * 1988-10-31 1990-05-17 Immunex Corporation Interleukin-4 receptors
US6596541B2 (en) * 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
PL2767161T3 (pl) 2004-10-19 2018-09-28 Regeneron Pharmaceuticals, Inc. Sposób wytwarzania zwierzęcia homozygotycznego pod względem modyfikacji genetycznej
JP2007252370A (ja) * 2006-02-22 2007-10-04 Institute Of Physical & Chemical Research Ｉｌ−４初期発現系トランスジェニック非ヒト動物およびその利用
US7608693B2 (en) * 2006-10-02 2009-10-27 Regeneron Pharmaceuticals, Inc. High affinity human antibodies to human IL-4 receptor
US20110016543A1 (en) 2008-12-04 2011-01-20 Sigma-Aldrich Co. Genomic editing of genes involved in inflammation
JP2012531896A (ja) * 2009-06-29 2012-12-13 チェン，チンフェン ヒト化非ヒト哺乳動物を製造する方法
WO2011011767A1 (en) * 2009-07-24 2011-01-27 Sigma-Aldrich Co. Method for genome editing
RU2425880C2 (ru) * 2009-07-30 2011-08-10 Учреждение Российской академии наук Институт общей генетики им. Н.И. Вавилова РАН Способ получения трансгенных мышей
ES3010323T3 (en) 2009-10-06 2025-04-02 Regeneron Pharma Genetically modified mice and engraftment
KR102714361B1 (ko) * 2011-02-15 2024-10-11 리제너론 파마슈티칼스 인코포레이티드 인간화된 ｍ－ｃｓｆ 마우스
KR101926442B1 (ko) 2011-10-28 2018-12-12 리제너론 파아마슈티컬스, 인크. 키메라 주요 조직적합성 복합체 （ｍｈｃ） ｉｉ 분자들을 발현하는 유전자 변형된 마우스
PL2663575T3 (pl) * 2011-10-28 2015-03-31 Regeneron Pharma Humanizowane IL-6 i receptor IL-6
DK2770821T3 (da) 2011-10-28 2017-11-27 Regeneron Pharma Genetisk modificerede major histocompatibility-kompleks-mus
US8962913B2 (en) * 2012-06-18 2015-02-24 Regeneron Pharmaceuticals, Inc. Humanized IL-7 rodents
RU2690675C2 (ru) * 2012-08-21 2019-06-05 Санофи Байотекнолоджи Способы лечения или предотвращения астмы посредством введения антагониста il-4r
KR102473555B1 (ko) 2012-09-07 2022-12-05 예일 유니버시티 유전적으로 변형된 비-인간 동물 및 이것들의 사용 방법
IL311744B2 (en) 2012-11-05 2025-10-01 Regeneron Pharma Genetically modified non-human animals and methods of using them
LT2958938T (lt) 2013-02-20 2019-07-25 Regeneron Pharmaceuticals, Inc. Pelės, ekspresuojančios humanizuotus t ląstelių koreceptorius
EP2958937B1 (en) 2013-02-22 2018-08-15 Regeneron Pharmaceuticals, Inc. Mice expressing humanized major histocompatibility complex
JO3532B1 (ar) 2013-03-13 2020-07-05 Regeneron Pharma الأجسام المضادة لمضاد انترلوكين-33 واستعمالاتها
PT4269430T (pt) 2013-09-23 2025-08-06 Regeneron Pharma Animais não-humanos com um gene humanizado de proteína reguladora de sinal
EP3138397B1 (en) 2013-10-15 2018-12-26 Regeneron Pharmaceuticals, Inc. Humanized il-15 animals
MX356809B (es) 2013-11-19 2018-06-13 Regeneron Pharma Animales no humanos que tienen un gen del factor activador de celulas b.
EP3071025B1 (en) 2013-11-19 2018-10-10 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized a proliferation-inducing ligand gene
RU2700484C2 (ru) 2014-04-08 2019-09-17 Регенерон Фармасьютикалз, Инк. Не относящиеся к человеку животные, имеющие гуманизированные fc-гамма-рецепторы
MX2016014504A (es) 2014-05-05 2017-05-23 Regeneron Pharma Animales c5 y c3 humanizados.
NO2785538T3 (OSRAM) * 2014-05-07 2018-08-04

Also Published As

Publication number Publication date
NZ725615A (en) 2024-05-31
IL297105B2 (en) 2024-01-01
NZ763861A (en) 2024-05-31
KR20220165814A (ko) 2022-12-15
PL3281521T3 (pl) 2022-01-03
CA2947307A1 (en) 2015-11-12
DK3027015T3 (en) 2018-01-22
PT3027015T (pt) 2018-02-09
US11963521B2 (en) 2024-04-23
SMT202100560T1 (it) 2021-11-12
AU2021218060A1 (en) 2021-09-09
IL304841A (en) 2023-09-01
RU2016143376A (ru) 2018-06-09
RU2016143376A3 (OSRAM) 2018-11-22
KR20160150637A (ko) 2016-12-30
LT3281521T (lt) 2021-09-27
JP2022171841A (ja) 2022-11-11
US20200022344A1 (en) 2020-01-23
EP3027015B1 (en) 2017-11-08
RU2019131253A (ru) 2019-12-06
JP2020058379A (ja) 2020-04-16
IL304841B1 (en) 2025-09-01
JP6640740B2 (ja) 2020-02-05
ES2887852T3 (es) 2021-12-28
NO2785538T3 (OSRAM) 2018-08-04
US20150320021A1 (en) 2015-11-12
WO2015171861A1 (en) 2015-11-12
US20180000056A1 (en) 2018-01-04
CA3207834A1 (en) 2015-11-12
IL248358B2 (en) 2023-03-01
JP2024159985A (ja) 2024-11-08
CN106470545A (zh) 2017-03-01
SG10201912354PA (en) 2020-02-27
PH12016502058A1 (en) 2017-01-09
KR102473565B1 (ko) 2022-12-02
CN110269047B (zh) 2021-11-02
LT3027015T (lt) 2018-01-25
US20170311580A1 (en) 2017-11-02
PT3281521T (pt) 2021-09-16
MX370672B (es) 2019-12-19
JP7755699B2 (ja) 2025-10-16
US9565841B2 (en) 2017-02-14
US9743647B2 (en) 2017-08-29
IL297105A (en) 2022-12-01
CN106470545B (zh) 2019-08-20
AU2021218060C1 (en) 2024-11-07
RS57073B1 (sr) 2018-06-29
US10477842B2 (en) 2019-11-19
US11109578B2 (en) 2021-09-07
EP3281521A1 (en) 2018-02-14
KR102517112B1 (ko) 2023-04-03
US12310340B2 (en) 2025-05-27
US20150320022A1 (en) 2015-11-12
US10588298B2 (en) 2020-03-17
SG11201608570YA (en) 2016-11-29
EP3027015A1 (en) 2016-06-08
US20210368753A1 (en) 2021-12-02
AU2021218060B2 (en) 2024-04-11
DK3281521T3 (da) 2021-09-20
EP3281521B1 (en) 2021-06-30
SI3281521T1 (sl) 2021-11-30
AU2024204694A1 (en) 2024-09-05
IL297105B1 (en) 2023-09-01
CY1124605T1 (el) 2022-07-22
JP2017514501A (ja) 2017-06-08
JP7145250B2 (ja) 2022-09-30
MX2016014563A (es) 2017-02-23
IL248358A0 (en) 2016-11-30
BR112016025745A2 (pt) 2018-01-16
IL248358B (en) 2022-11-01
US20230027494A1 (en) 2023-01-26
RS62345B1 (sr) 2021-10-29
ES2656529T3 (es) 2018-02-27
PL3027015T3 (pl) 2018-04-30
HUE038028T2 (hu) 2018-09-28
JP6838131B2 (ja) 2021-03-03
CY1119773T1 (el) 2018-06-27
RU2703139C2 (ru) 2019-10-15
SMT201800018T1 (it) 2018-03-08
SI3027015T1 (en) 2018-02-28
EP3906781A1 (en) 2021-11-10
JP2021087434A (ja) 2021-06-10
AU2015255977A1 (en) 2016-11-17
AU2015255977B2 (en) 2021-09-02
CA2947307C (en) 2023-09-26
HRP20211455T1 (hr) 2022-01-07
CN110269047A (zh) 2019-09-24
HUE055860T2 (hu) 2021-12-28
HRP20180242T1 (hr) 2018-03-09

Similar Documents

Publication Publication Date Title
AU2021218060B2 (en) Humanized il-4 and il-4r alpha animals
HK40053187A (en) Humanized il-4 and il-4r alpha animals
RU2788523C2 (ru) ЖИВОТНЫЕ С ГУМАНИЗИРОВАННЫМИ IL-4 И IL-4Rα
HK1245011A1 (en) Humanized il-4 and il-4r alpha animals
HK1245011B (en) Humanized il-4 and il-4r alpha animals
HK1225575A1 (en) Humanized il-4 and il-4r alpha animals
HK1225575B (en) Humanized il-4 and il-4r alpha animals

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20230728

EEER Examination request

Effective date: 20230728

EEER Examination request

Effective date: 20230728

EEER Examination request

Effective date: 20230728